Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC
Public ClinicalTrials.gov record NCT02504489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Blinded Phase III Assessment of Second or Third-Line Chemotherapy With Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced Non-Small Cell Lung Cancer and With at Least One Measurable Lung Lesion
Study identification
- NCT ID
- NCT02504489
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- BeyondSpring Pharmaceuticals Inc.
- Industry
- Enrollment
- 559 participants
Conditions and interventions
Conditions
Interventions
- Docetaxel (D) Drug
- Docetaxel + Plinabulin (DP) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2015
- Primary completion
- Jul 20, 2021
- Completion
- Oct 29, 2023
- Last update posted
- May 18, 2026
2015 – 2023
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer & Research Centers | Chandler | Arizona | 85224 | — |
| Pacific Cancer Medical Center, Inc. | Anaheim | California | 92801 | — |
| Innovative Clinical Research Institute | Whittier | California | 90603 | — |
| Memorial Health Care System | Colorado Springs | Colorado | 80909 | — |
| Cancer Center of Central Connecticut | Plainville | Connecticut | 06062 | — |
| Peachtree Hematoloy-Oncology Consultants, PC | Atlanta | Georgia | 30318 | — |
| Orchard Healthcare Research Inc. | Skokie | Illinois | 60077 | — |
| Carle Cancer Center | Urbana | Illinois | 61801 | — |
| Kansas University Medical Center | Westwood | Kansas | 00913 | — |
| University of Louisville-Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Michigan Center of Medical Research | Farmington Hills | Michigan | 48334 | — |
| Hattiesburg Clinic Hematology/Oncology | Hattiesburg | Mississippi | 39401 | — |
| Central Care Cancer Center | Bolivar | Missouri | 65613 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Toledo Cancer Center | Toledo | Ohio | 43623 | — |
| Allegheny Health Network | Pittsburgh | Pennsylvania | 15212 | — |
| Cookeville Regional Medical Center Cancer Center | Cookeville | Tennessee | 61801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02504489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02504489 live on ClinicalTrials.gov.